Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis

The combination of intermittent fasting and chemotherapy can improve the response to treatment. Here, the authors show that SIRT7 activation is required to inactivate Akt during intermittent fasting and that the combination of intermittent fasting and inhibitors that block the Erk pathway can improv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaolong Tang, Guo Li, Lei Shi, Fengting Su, Minxian Qian, Zuojun Liu, Yuan Meng, Shimin Sun, Ji Li, Baohua Liu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/b558c32cb2f94905887f6a978bd50b73
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b558c32cb2f94905887f6a978bd50b73
record_format dspace
spelling oai:doaj.org-article:b558c32cb2f94905887f6a978bd50b732021-12-02T19:02:36ZCombined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis10.1038/s41467-021-25274-32041-1723https://doaj.org/article/b558c32cb2f94905887f6a978bd50b732021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25274-3https://doaj.org/toc/2041-1723The combination of intermittent fasting and chemotherapy can improve the response to treatment. Here, the authors show that SIRT7 activation is required to inactivate Akt during intermittent fasting and that the combination of intermittent fasting and inhibitors that block the Erk pathway can improve efficacy of treatment.Xiaolong TangGuo LiLei ShiFengting SuMinxian QianZuojun LiuYuan MengShimin SunJi LiBaohua LiuNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Xiaolong Tang
Guo Li
Lei Shi
Fengting Su
Minxian Qian
Zuojun Liu
Yuan Meng
Shimin Sun
Ji Li
Baohua Liu
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
description The combination of intermittent fasting and chemotherapy can improve the response to treatment. Here, the authors show that SIRT7 activation is required to inactivate Akt during intermittent fasting and that the combination of intermittent fasting and inhibitors that block the Erk pathway can improve efficacy of treatment.
format article
author Xiaolong Tang
Guo Li
Lei Shi
Fengting Su
Minxian Qian
Zuojun Liu
Yuan Meng
Shimin Sun
Ji Li
Baohua Liu
author_facet Xiaolong Tang
Guo Li
Lei Shi
Fengting Su
Minxian Qian
Zuojun Liu
Yuan Meng
Shimin Sun
Ji Li
Baohua Liu
author_sort Xiaolong Tang
title Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
title_short Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
title_full Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
title_fullStr Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
title_full_unstemmed Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
title_sort combined intermittent fasting and erk inhibition enhance the anti-tumor effects of chemotherapy via the gsk3β-sirt7 axis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b558c32cb2f94905887f6a978bd50b73
work_keys_str_mv AT xiaolongtang combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT guoli combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT leishi combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT fengtingsu combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT minxianqian combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT zuojunliu combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT yuanmeng combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT shiminsun combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT jili combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
AT baohualiu combinedintermittentfastinganderkinhibitionenhancetheantitumoreffectsofchemotherapyviathegsk3bsirt7axis
_version_ 1718377232309682176